Sponsored by Pfizer

Articles by Sponsored by Pfizer

A Changing Treatment Landscape for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

BySponsored by Pfizer

December 4th 2025

Sponsored Content

Bispecific antibodies in multiple myeloma: revolutionizing blood cancer immunotherapy

ByDr. Jeff Settleman, Ph.D., Chief Scientific Officer, Oncology Research and Development, Pfizer ,Sponsored by Pfizer

June 21st 2024

Bridging Gaps, Expanding Outreach: Identifying the Unmet Needs of Women Living with Metastatic Breast Cancer

BySponsored by Pfizer

September 19th 2008

The purpose of this Priority Report is to raise awareness of metastatic breast cancer.

Latest Updated Articles

Bispecific antibodies in multiple myeloma: revolutionizing blood cancer immunotherapy
June 21st 2024
Bridging Gaps, Expanding Outreach: Identifying the Unmet Needs of Women Living with Metastatic Breast Cancer
September 19th 2008

Trending on OncLive

Pumitamig Plus Elfetabart Drozuntecan Elicits 70% ORR Across Lines of Therapy in SCLC

SERENA-4 Misses Primary PFS End Point With Camizestrant Plus Palbociclib in First-Line ER+ Advanced Breast Cancer

Extended-Interval Tarlatamab Yields Comparable Exposure, Survival to Q2W Dose in Previously Treated SCLC

Dr Grant's Advice for Early-Career Oncologists at WCLC 2026

LCT After Nivolumab/Ipilimumab Induction Fails to Improve Metastatic NSCLC Survival